Article
Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.
Blood cells, molecules & diseases - 1 Jan 2000
Neufeld E J, Fleming J C, Tartaglini E, Steinkamp M P
Abstract excerpt
Thiamine-responsive megaloblastic anemia (TRMA) syndrome (OMIM No. 249270) comprises a distinctive triad of clinical features: megaloblastic anemia with ringed sideroblasts, diabetes mellitus, and progressive sensorineural deafness. The TRMA gene has been mapped and cloned. Designated "SLC19A2" as a member of the solute carrier gene superfamily, this gene is mutated in all TRMA kindreds studied to date. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
